JW Lifescience Corporation (KRX:234080)
13,700
-160 (-1.15%)
Last updated: Nov 5, 2025, 9:09 AM KST
JW Lifescience Market Cap
JW Lifescience has a market cap or net worth of 204.55 billion as of November 5, 2025. Its market cap has increased by 19.33% in one year.
Market Cap
204.55B
Enterprise Value
233.80B
Revenue
243.64B
Ranking
n/a
PE Ratio
4.13
Stock Price
13,700.00
Market Cap Chart
Since October 27, 2016, JW Lifescience's market cap has decreased from 340.05B to 204.55B, a decrease of -39.85%. That is a compound annual growth rate of -5.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 204.55B | 21.42% |
| Dec 30, 2024 | 168.47B | -15.46% |
| Dec 28, 2023 | 199.29B | 5.93% |
| Dec 29, 2022 | 188.14B | -12.27% |
| Dec 30, 2021 | 214.46B | -34.73% |
| Dec 30, 2020 | 328.57B | 4.80% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.53T |
| ALTEOGEN | 28.29T |
| SK Biopharmaceuticals | 9.44T |
| Yuhan | 8.71T |
| HLB Co., Ltd. | 7.03T |
| ABL Bio | 6.13T |
| Peptron | 6.11T |